(Q70616864)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Calcium kinetics and the long-term effects of lowering dialysate calcium concentration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

author name string

A Argilés

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

P G Kerr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

B Canaud

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

J L Flavier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

C Mion

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

language of work or name

English

0 references

publication date

1 March 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

630-640

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1993.92

12 October 2019

exact match

0 references

cites work

Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Optimum dialysate calcium concentration during maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Kinetic modeling: applications in renal and related diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

A mechanistic analysis of the National Cooperative Dialysis Study (NCDS)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

The dialysis encephalopathy syndrome. Possible aluminum intoxication

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

The Treatment of Uraemic Hyperphosphataemia with Calcium Acetate and Calcium Carbonate: A Comparative Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Clinical experience with intermittent hemodiafiltrations.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Comparison of hemodialysis and hemodiafiltration: a long-term longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Calcium Flux During Hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Serum Calcium in Blood Pressure Regulation During Hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Ionized calcium plays a pivotal role in controlling blood pressure during haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Calcium effect on performance of the heart

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Effect of cations on resistance and responsiveness of renal and forelimb vascular beds

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Blood pressure response to changes in serum ionized calcium during hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

The effect of dialysate calcium levels on blood pressure during hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Treatment of refractory hyperparathyroidism in patients on hemodialysis by intermittent oral administration of 1,25(OH)2vitamin D3.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Oral administration of 24,25(OH)2D3 suppresses the serum parathyroid hormone levels of dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Circulating 1,25-dihydroxycholecalciferol after intravenous injections of 1 alpha-hydroxycholecalciferol in patients on regular haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Effects on serum parathyroid hormone of intravenous treatment with alphacalcidol in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.92

7 January 2021

Identifiers

DOI

10.1038/KI.1993.92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8455362%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference